Vik Chopra
Stock Analyst at Wells Fargo
(3.77)
# 766
Out of 4,711 analysts
27
Total ratings
66.67%
Success rate
6.62%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Overweight | $88 → $95 | $82.63 | +14.97% | 8 | Dec 11, 2024 | |
| MASI Masimo | Maintains: Overweight | $171 → $193 | $169.52 | +13.85% | 7 | Dec 11, 2024 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $11.53 | +12.75% | 2 | Nov 13, 2024 | |
| NVST Envista Holdings | Initiates: Equal-Weight | $20 | $18.70 | +6.95% | 1 | Oct 8, 2024 | |
| SOLV Solventum | Maintains: Equal-Weight | $69 → $64 | $66.83 | -4.23% | 2 | Aug 9, 2024 | |
| CNMD CONMED | Maintains: Equal-Weight | $77 → $71 | $68.63 | +3.45% | 2 | Aug 1, 2024 | |
| ATEC Alphatec Holdings | Maintains: Overweight | $26 → $19 | $9.35 | +103.21% | 1 | Aug 1, 2024 | |
| IART Integra LifeSciences Holdings | Downgrades: Equal-Weight | $45 → $25 | $21.80 | +14.68% | 1 | May 7, 2024 | |
| ENOV Enovis | Maintains: Overweight | $73 → $79 | $43.12 | +83.21% | 3 | Feb 23, 2024 |
Globus Medical
Dec 11, 2024
Maintains: Overweight
Price Target: $88 → $95
Current: $82.63
Upside: +14.97%
Masimo
Dec 11, 2024
Maintains: Overweight
Price Target: $171 → $193
Current: $169.52
Upside: +13.85%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $11.53
Upside: +12.75%
Envista Holdings
Oct 8, 2024
Initiates: Equal-Weight
Price Target: $20
Current: $18.70
Upside: +6.95%
Solventum
Aug 9, 2024
Maintains: Equal-Weight
Price Target: $69 → $64
Current: $66.83
Upside: -4.23%
CONMED
Aug 1, 2024
Maintains: Equal-Weight
Price Target: $77 → $71
Current: $68.63
Upside: +3.45%
Alphatec Holdings
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $9.35
Upside: +103.21%
Integra LifeSciences Holdings
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45 → $25
Current: $21.80
Upside: +14.68%
Enovis
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $43.12
Upside: +83.21%